EMA Advances Under-the-skin Injection of Entyvio for Crohn’s and Ulcerative Colitis
News
The European Medicines Agency (EMA) has accepted a Marketing Authorization Line Extension Application for a new subcutaneous (under-the-skin) form of Entyvio (vedolizumab). Entyvio is a biologic agent developed by Millenium ... Read more